#Ozempic #Mounjaro #GLP1 #WeightLoss #ObesityMedicine Some foods can make Ozempic or Mounjaro side effects much worse — even if you're taking the medication exactly as prescribed. In this video, Dr. Mohammed Paika (board-certified in Internal Medicine and Obesity Medicine) breaks down the 5 food categories most likely to cause nausea, reflux, and bloating on a GLP-1 medication — and exactly what to eat instead to support fat loss without fighting your own treatment. 🎓 Complete GLP-1 Weight Loss Masterclass — Lifetime AccessComprehensive education on GLP-1 medications, nutrition, exercise, muscle preservation, side effects & long-term success. Includes the companion eBook, quizzes, 12-week exercise program, certificate & future course updates at no additional cost.https://www.drmohammedpaika.com 📩 FREE GLP-1 Diet Cookbook + Weekly NewsletterGet weekly evidence-based insights on GLP-1s, metabolic health, nutrition, exercise & longevity.https://www.drmohammedpaika.com/newsletter 📚 The Weight Equation & The Physician’s PhysiquePhysician-written, evidence-based guides to obesity, weight loss, nutrition, metabolism, exercise, body composition & healthier living.https://www.drmohammedpaika.com/books 👥 Metabolic Health CommunityLive Q&As, evidence-based education, accountability, workouts, nutrition guidance & community support.https://www.skool.com/metabolic-health-community-5316 Timestamps:0:00 Hook0:51 Who I Am & Why This Matters3:11 Fried & Greasy Foods6:30 Alcohol9:37 A Quick Word (GLP-1 Masterclass)10:54 Easy-to-Overeat Carbs13:01 Candy & Processed Sweets15:23 Sugary Drinks18:54 The Mindset That Actually Works20:37 End-Screen / Resources 👨⚕️ ABOUT DR. MOHAMMED K. PAIKABoard-Certified in Internal Medicine and Obesity MedicineCertified Personal Trainer & Nutrition CoachHelping people understand metabolism, hormones, and sustainable health through evidence-based medicine. References:Jelsing et al., 2012, Diabetes Obes Metab — https://pubmed.ncbi.nlm.nih.gov/22226053/Little et al., 2005, Obes Rev — https://doi.org/10.1111/j.1467-789X.2005.00212.xSodhi et al., 2023, JAMA — https://pubmed.ncbi.nlm.nih.gov/37796527/Suter et al., 1992, N Engl J Med — https://www.nejm.org/doi/full/10.1056/NEJM199204093261503American Diabetes Association, 2024, Standards of Care — https://diabetesjournals.org/care/issue/47/Supplement_1Graybiel, 2008, Annu Rev Neurosci — https://pubmed.ncbi.nlm.nih.gov/18558860/Hall et al., 2019, Cell Metab — https://pubmed.ncbi.nlm.nih.gov/31105044/Nauck & Meier, 2018, Diabetes Obes Metab — https://pubmed.ncbi.nlm.nih.gov/29364588/Wilding et al., 2021, N Engl J Med (STEP 1 trial) — https://pubmed.ncbi.nlm.nih.gov/33567185/McDonald's — Large Sweet Tea nutrition — https://www.mcdonalds.com/us/en-us/product/southern-style-sweet-tea-large.htmlStarbucks — Caramel Frappuccino nutrition — https://www.starbucks.com/menu/product-info/?product=caramel-frappuccino-blended-beverageVolkow, Wang & Baler, 2011, Trends Cogn Sci — https://pubmed.ncbi.nlm.nih.gov/21109477/DiMeglio & Mattes, 2000, Int J Obes — https://pubmed.ncbi.nlm.nih.gov/10878689/ ⚕️ MEDICAL & EDUCATIONAL DISCLAIMERThis channel and its content are provided by Dr. Mohammed K. Paika, MD for general educational and informational purposes only. The information presented is not intended as medical advice and does not replace consultation with your personal physician or qualified healthcare professional.Viewing this content does not create a doctor-patient relationship between you and Dr. Paika.Health, nutrition, exercise, and medication topics discussed on this channel may not be appropriate for all individuals. Always consult your own healthcare provider before starting or changing any medication, diet, exercise program, or weight-loss plan, including GLP-1 therapies such as Wegovy, Ozempic, Zepbound, Mounjaro, or similar medications.Exercise and lifestyle changes carry inherent risks. By choosing to follow any information from this channel, you accept full responsibility for your health decisions and outcomes.Dr. Paika and affiliated entities disclaim any liability for injuries, adverse effects, or damages resulting from use or application of information presented in this content.